Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis

Jiangyi Wu; Jinhui Wu; Wei Xiang; Yunquan Gong; Daibo Feng; Shunzheng Fang; Yaran Wu; Zheng Liu; Yang Li; Ran Chen; Xiaoqi Zhang; Bingfei Li; Lifeng Chen; Runze Jin; Li Song; Bin Zhang; Tongyi Zhang; Lin Yin; Yizhao Zhou; Shu Huang; Ningning Liu; Haojie Xu; Jiqin Lian; Yongqian Wang; Siru Zhou; Zhenhong Ni

doi:10.1186/s12951-024-02795-9

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

TNF-α preconditioning constitutes an effective and promising method for optimizing the therapeutic effects of IPFP-MSCs derived exosomes in the treatment of OA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2024) studied this question.

synapsesocial.com/papers/69df2bbe7ae893756261408e https://doi.org/10.1186/s12951-024-02795-9

View Full Paper

Ask AI

Bookmark

Share

Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis

Ask about this paper

Abstract

Discussion

Cite This Study

Engineering exosomes derived from TNF-α preconditioned IPFP-MSCs enhance both yield and therapeutic efficacy for osteoarthritis

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading